• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Pharmacological interventions in the treatment of the acute effects of cannabis: a systematic review of literature.药物干预治疗大麻急性效应的研究:文献系统评价。
Harm Reduct J. 2012 Jan 25;9:7. doi: 10.1186/1477-7517-9-7.
2
[Therapeutical use of the cannabinoids in psychiatry].大麻素在精神病学中的治疗应用
Braz J Psychiatry. 2010 May;32 Suppl 1:S56-66.
3
Systematic reviews of the effectiveness of day care for people with severe mental disorders: (1) acute day hospital versus admission; (2) vocational rehabilitation; (3) day hospital versus outpatient care.针对重度精神障碍患者日间护理效果的系统评价:(1)急性日间医院与住院治疗对比;(2)职业康复;(3)日间医院与门诊护理对比。
Health Technol Assess. 2001;5(21):1-75. doi: 10.3310/hta5210.
4
Cannabidiol, a Cannabis sativa constituent, as an anxiolytic drug.大麻二酚,一种大麻属植物的成分,作为一种抗焦虑药物。
Braz J Psychiatry. 2012 Jun;34 Suppl 1:S104-10. doi: 10.1590/s1516-44462012000500008.
5
Psychological and psychosocial interventions for cannabis cessation in adults: a systematic review short report.成人大麻戒断的心理和社会心理干预:系统评价简短报告
Health Technol Assess. 2015 Jul;19(56):1-130. doi: 10.3310/hta19560.
6
Pharmacological Treatment of Cannabis-Related Disorders: A Narrative Review.大麻相关障碍的药物治疗:一篇叙述性综述。
Curr Pharm Des. 2016;22(42):6409-6419. doi: 10.2174/1381612822666160822150822.
7
Treatment of cannabis use among people with psychotic or depressive disorders: a systematic review.治疗精神分裂症或抑郁症患者的大麻使用问题:系统评价。
J Clin Psychiatry. 2010 Mar;71(3):247-54. doi: 10.4088/JCP.09r05119gry.
8
Interventions for adults with a history of complex traumatic events: the INCiTE mixed-methods systematic review.干预成年人创伤后复杂经历:INCiTE 混合方法系统综述。
Health Technol Assess. 2020 Sep;24(43):1-312. doi: 10.3310/hta24430.
9
Risks associated with the non-medicinal use of cannabis.与大麻非药用使用相关的风险。
Dtsch Arztebl Int. 2015 Apr 17;112(16):271-8. doi: 10.3238/arztebl.2015.0271.
10
The Effectiveness of Integrated Care Pathways for Adults and Children in Health Care Settings: A Systematic Review.综合护理路径在医疗环境中对成人和儿童的有效性:一项系统评价。
JBI Libr Syst Rev. 2009;7(3):80-129. doi: 10.11124/01938924-200907030-00001.

引用本文的文献

1
Fentanyl Smoking in San Francisco: Early Signs of a New Connoisseurship.旧金山的芬太尼吸食现象:新癖好的早期迹象
Hum Organ. 2024;83(4):303-314. doi: 10.1080/00187259.2024.2361846. Epub 2024 Jul 3.
2
Efficacy of cannabidiol alone or in combination with Δ-9-tetrahydrocannabinol for the management of substance use disorders: An umbrella review of the evidence.大麻二酚单独或与Δ-9-四氢大麻酚联合用于物质使用障碍管理的疗效:证据的综合评价。
Addiction. 2025 May;120(5):813-834. doi: 10.1111/add.16745. Epub 2025 Feb 13.
3
Ethnobotany and Toxicity Status of Medicinal Plants with Cosmeceutical Relevance from Eastern Cape, South Africa.南非东开普省具有药妆相关性的药用植物的民族植物学与毒性状况
Plants (Basel). 2022 May 30;11(11):1451. doi: 10.3390/plants11111451.
4
Cannabis and the Current State of Treatment for Cannabis Use Disorder.大麻与大麻使用障碍的当前治疗状况
Focus (Am Psychiatr Publ). 2019 Apr;17(2):98-103. doi: 10.1176/appi.focus.20180038. Epub 2019 Apr 10.
5
Translational Investigation of the Therapeutic Potential of Cannabidiol (CBD): Toward a New Age.翻译为简体中文后的文本如下: 大麻二酚(CBD)治疗潜力的转化研究:迈向新时代。
Front Immunol. 2018 Sep 21;9:2009. doi: 10.3389/fimmu.2018.02009. eCollection 2018.
6
Cannabis Addiction and the Brain: a Review.大麻成瘾与大脑:综述。
J Neuroimmune Pharmacol. 2018 Dec;13(4):438-452. doi: 10.1007/s11481-018-9782-9. Epub 2018 Mar 19.
7
Risks associated with the non-medicinal use of cannabis.与大麻非药用使用相关的风险。
Dtsch Arztebl Int. 2015 Apr 17;112(16):271-8. doi: 10.3238/arztebl.2015.0271.
8
Marijuana: current concepts(†).大麻:当前的概念(†)。
Front Public Health. 2013 Oct 10;1:42. doi: 10.3389/fpubh.2013.00042.

本文引用的文献

1
Cannabidiol reduces the anxiety induced by simulated public speaking in treatment-naïve social phobia patients.大麻二酚可降低治疗初发社交恐惧症患者在模拟公开演讲时的焦虑。
Neuropsychopharmacology. 2011 May;36(6):1219-26. doi: 10.1038/npp.2011.6. Epub 2011 Feb 9.
2
Neural basis of anxiolytic effects of cannabidiol (CBD) in generalized social anxiety disorder: a preliminary report.广泛性社交焦虑障碍中大麻二酚(CBD)抗焦虑作用的神经基础:一项初步研究报告。
J Psychopharmacol. 2011 Jan;25(1):121-30. doi: 10.1177/0269881110379283. Epub 2010 Sep 9.
3
[Therapeutical use of the cannabinoids in psychiatry].大麻素在精神病学中的治疗应用
Braz J Psychiatry. 2010 May;32 Suppl 1:S56-66.
4
[Pharmacological and psychosocial interventions for cannabis use disorders].[针对大麻使用障碍的药理和心理社会干预措施]
Braz J Psychiatry. 2010 May;32 Suppl 1(0 1):S46-55.
5
[Cannabis abuse in patients with psychiatric disorders: an update to old evidence].[精神疾病患者中的大麻滥用:旧证据的更新]
Braz J Psychiatry. 2010 May;32 Suppl 1:S41-5.
6
[Cognitive abnormalities and cannabis use].[认知异常与大麻使用]
Braz J Psychiatry. 2010 May;32 Suppl 1:S31-40.
7
[Pharmacological exploitation of the endocannabinoid system: new perspectives for the treatment of depression and anxiety disorders?].[内源性大麻素系统的药理学应用:治疗抑郁症和焦虑症的新前景?]
Braz J Psychiatry. 2010 May;32 Suppl 1:S7-14.
8
[Cannabis sativa: the plant that can induce unwanted effects and also treat them].[大麻:既能引发不良影响又能治疗这些影响的植物]
Braz J Psychiatry. 2010 May;32 Suppl 1:S1-2.
9
Cannabis and anxiety: a critical review of the evidence.大麻与焦虑:证据的批判性综述。
Hum Psychopharmacol. 2009 Oct;24(7):515-23. doi: 10.1002/hup.1048.
10
Evaluation of a urine on-site drugs of abuse screening test in patients admitted to a psychiatric emergency unit.对入住精神科急诊病房的患者进行尿液现场滥用药物筛查试验的评估。
J Clin Psychopharmacol. 2009 Jun;29(3):248-54. doi: 10.1097/JCP.0b013e3181a45e78.

药物干预治疗大麻急性效应的研究:文献系统评价。

Pharmacological interventions in the treatment of the acute effects of cannabis: a systematic review of literature.

机构信息

Department of Neurosciences and Behavior, Ribeirão Preto Medical School, University of São Paulo and INCT Translational Medicine (CNPq), Brazil.

出版信息

Harm Reduct J. 2012 Jan 25;9:7. doi: 10.1186/1477-7517-9-7.

DOI:10.1186/1477-7517-9-7
PMID:22273390
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3294246/
Abstract

BACKGROUND

Cannabis intoxication is related to a number of physical and mental health risks with ensuing social costs. However, little attention has been given to the investigation of possible pharmacological interactions in this condition.

OBJECTIVE

To review the available scientific literature concerning pharmacological interventions for the treatment of the acute effects of cannabis.

METHODS

A search was performed on the Pubmed, Lilacs, and Scielo online databases by combining the terms cannabis, intoxication, psychosis, anxiety, and treatment. The articles selected from this search had their reference lists checked for additional publications related to the topic of the review.

RESULTS

The reviewed articles consisted of case reports and controlled clinical trials and are presented according to interventions targeting the physiological, psychiatric, and cognitive symptoms provoked by cannabis. The pharmacological interventions reported in these studies include: beta-blockers, antiarrhythmic agents, antagonists of CB-1 and GABA-benzodiazepine receptors, antipsychotics, and cannabidiol.

CONCLUSION

Although scarce, the evidence on pharmacological interventions for the management of cannabis intoxication suggests that propanolol and rimonabant are the most effective compounds currently available to treat the physiological and subjective effects of the drug. Further studies are necessary to establish the real effectiveness of these two medications, as well as the effectiveness of other candidate compounds to counteract the effects of cannabis intoxication, such as cannabidiol and flumazenil.

摘要

背景

大麻中毒与许多身心健康风险相关,并带来相应的社会成本。然而,对于这种情况下可能存在的药物相互作用,人们关注甚少。

目的

综述现有关于大麻急性作用治疗的药理学干预措施的科学文献。

方法

通过将大麻、中毒、精神病、焦虑和治疗等术语组合,在 Pubmed、Lilacs 和 Scielo 在线数据库中进行检索。从这次检索中选择的文章,还会检查其参考文献中是否有与综述主题相关的其他出版物。

结果

综述中包含病例报告和对照临床试验,并根据针对大麻引起的生理、精神和认知症状的干预措施进行呈现。这些研究报告的药理学干预措施包括:β受体阻滞剂、抗心律失常药物、CB-1 和 GABA-苯二氮䓬受体拮抗剂、抗精神病药和大麻二酚。

结论

尽管证据有限,但关于大麻中毒管理的药理学干预措施的证据表明,普萘洛尔和利莫那班是目前治疗药物生理和主观作用最有效的化合物。需要进一步的研究来确定这两种药物的真正有效性,以及其他候选化合物(如大麻二酚和氟马西尼)对抗大麻中毒作用的有效性。